Gonzalez-Garcia C, Keiser H R
Hypertension-Endocrine Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892.
J Hypertens. 1990 May;8(5):433-41. doi: 10.1097/00004872-199005000-00007.
Binding sites for angiotensin II (Ang II) and angiotensin converting enzyme (ACE) were studied by autoradiography in human, rat and bovine adrenals and human pheochromocytomas. In human and rat adrenals, binding sites for both Ang II and ACE were found in the medulla and zona glomerulosa. In bovine adrenals, ACE binding sites were not detectable, while Ang II binding was higher in the zona glomerulosa, lower in the rest of the cortex and undetectable in the medulla. In pheochromocytomas, ACE binding was homogeneously distributed, but no Ang II binding was detected. These results suggest that circulating and/or locally formed Ang II could regulate adrenomedullary and zona glomerulosa functions in man, and show that chromaffin cells in tumors retain ACE binding sites but lose Ang II binding sites. Thus, there are alterations in the regulation of the renin-angiotensin system in chromaffin tumors.
通过放射自显影技术,对人、大鼠和牛的肾上腺以及人嗜铬细胞瘤中血管紧张素II(Ang II)和血管紧张素转换酶(ACE)的结合位点进行了研究。在人和大鼠的肾上腺中,Ang II和ACE的结合位点均见于髓质和球状带。在牛的肾上腺中,未检测到ACE结合位点,而球状带中Ang II结合较高,皮质其他部位较低,髓质中未检测到。在嗜铬细胞瘤中,ACE结合呈均匀分布,但未检测到Ang II结合。这些结果表明,循环和/或局部形成的Ang II可能调节人类肾上腺髓质和球状带的功能,并表明肿瘤中的嗜铬细胞保留ACE结合位点,但失去Ang II结合位点。因此,嗜铬细胞瘤中肾素-血管紧张素系统的调节存在改变。